Overview Cefprozil 500 mg Tablets Under Fed Conditions Status: Completed Trial end date: 2003-09-01 Target enrollment: Participant gender: Summary The objective of this study is to compare the relative bioavailability of cefprozil 500 mg tablets with that of Cefzil 500 mg tablets in healthy, non-smoking adults under non-fasting conditions. Phase: Phase 1 Details Lead Sponsor: Teva Pharmaceuticals USATreatments: CefprozilCephalosporins